Eledon Pharmaceuticals, Inc. Capital Expenditures
Eledon Pharmaceuticals, Inc. (ELDN) reported Capital Expenditures of $9.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2018-04-02.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2018-04-02
- Eledon Pharmaceuticals, Inc. payments to acquire property, plant, and equipment for the quarter ending 2016-12-31 was -$3.00K, a 101.39% decline year-over-year.
- Eledon Pharmaceuticals, Inc. payments to acquire property, plant, and equipment for the quarter ending 2016-09-30 was $2.00K, a 98.73% decline year-over-year.
- Eledon Pharmaceuticals, Inc. payments to acquire property, plant, and equipment for the quarter ending 2016-06-30 was -$7.00K, a 104.76% decline year-over-year.
- Eledon Pharmaceuticals, Inc. payments to acquire property, plant, and equipment for the quarter ending 2016-03-31 was $17.00K, a 62.22% decline year-over-year.
- Eledon Pharmaceuticals, Inc. payments to acquire property, plant, and equipment for fiscal 2016 was $9.00K, a 98.41% decline from fiscal 2015.
- Eledon Pharmaceuticals, Inc. payments to acquire property, plant, and equipment for fiscal 2015 was $565.00K, a 2160.00% increase from fiscal 2014.
- Eledon Pharmaceuticals, Inc. payments to acquire property, plant, and equipment for fiscal 2014 was $25.00K, a 8.70% increase from fiscal 2013.
- Eledon Pharmaceuticals, Inc. payments to acquire property, plant, and equipment for fiscal 2013 was $23.00K, a 187.50% increase from fiscal 2012.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 6 month as first filed | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 9 month as first filed | Payments to Acquire Property, Plant, and Equipment 12 month | Payments to Acquire Property, Plant, and Equipment 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2016-12-31 | -$3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | -$1.00K derived: sum of 2 quarters · filed 2018-04-02 | -$8.00K derived: sum of 3 quarters · filed 2018-04-02 | $9.00K 10-K · filed 2018-04-02 | $17.00K 10-K · filed 2017-03-03 | ||
| 2016-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$5.00K derived: sum of 2 quarters · filed 2017-11-08 | $12.00K 10-Q · filed 2017-11-08 | $17.00K 10-Q · filed 2016-11-03 | $228.00K derived: sum of 4 quarters · filed 2017-11-08 | ||
| 2016-06-30 | -$7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $10.00K 10-Q · filed 2017-08-09 | $17.00K 10-Q · filed 2016-08-04 | $226.00K derived: sum of 3 quarters · filed 2017-08-09 | $383.00K derived: sum of 4 quarters · filed 2017-08-09 | ||
| 2016-03-31 | $17.00K 10-Q · filed 2017-05-03 | $233.00K derived: sum of 2 quarters · filed 2017-05-03 | $390.00K derived: sum of 3 quarters · filed 2017-05-03 | $537.00K derived: sum of 4 quarters · filed 2017-05-03 | |||
| 2015-12-31 | $216.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | $373.00K derived: sum of 2 quarters · filed 2017-03-03 | $520.00K derived: sum of 3 quarters · filed 2017-03-03 | $565.00K 10-K · filed 2017-03-03 | |||
| 2015-09-30 | $157.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $304.00K derived: sum of 2 quarters · filed 2016-11-03 | $349.00K 10-Q · filed 2016-11-03 | $349.00K derived: sum of 4 quarters · filed 2017-03-03 | |||
| 2015-06-30 | $147.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $192.00K 10-Q · filed 2016-08-04 | $192.00K derived: sum of 3 quarters · filed 2017-03-03 | $199.00K derived: sum of 4 quarters · filed 2017-03-03 | |||
| 2015-03-31 | $45.00K 10-Q · filed 2016-05-10 | $45.00K derived: sum of 2 quarters · filed 2017-03-03 | $52.00K derived: sum of 3 quarters · filed 2017-03-03 | $58.00K derived: sum of 4 quarters · filed 2017-03-03 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | $7.00K derived: sum of 2 quarters · filed 2017-03-03 | $13.00K derived: sum of 3 quarters · filed 2017-03-03 | $25.00K 10-K · filed 2017-03-03 | |||
| 2014-09-30 | $7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | $13.00K derived: sum of 2 quarters · filed 2015-11-10 | $25.00K 10-Q · filed 2015-11-10 | $29.00K derived: sum of 4 quarters · filed 2016-03-10 | |||
| 2014-06-30 | $6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $18.00K 10-Q · filed 2015-08-12 | $22.00K derived: sum of 3 quarters · filed 2016-03-10 | ||||
| 2014-03-31 | $12.00K 10-Q · filed 2015-05-12 | $16.00K derived: sum of 2 quarters · filed 2016-03-10 | |||||
| 2013-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $23.00K 10-K · filed 2016-03-10 | |||||
| 2013-09-30 | $19.00K 10-Q · filed 2014-11-13 | ||||||
| 2012-12-31 | $8.00K 10-K · filed 2015-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |